
Nexperia
Dutch-based, Chinese-owned semiconductor chipmaker at the centre of a Dutch export-control intervention.
Nexperia is the Nijmegen-based, Wingtech-owned chipmaker whose Dutch and Chinese overseers are still negotiating a way out of the 2025-26 supply dispute; Beijing pressed for consultation on 16 July 2026.
Last refreshed: 26 July 2026 · Appears in 1 active topic
Could Beijing and The Hague's talks finally end the chip standoff choking Europe's carmakers?
Timeline for Nexperia
Dutch-based chipmaker at the centre of the dispute
European Tech Sovereignty: Beijing urges Dutch talks to settle Nexperia disputeBackground
Nexperia is a semiconductor manufacturer headquartered in Nijmegen, the Netherlands, tracing its roots to Philips' former discrete and standard-product chip business. It makes discrete semiconductors, including diodes, transistors and MOSFETs, widely used in automotive and consumer electronics, and has been owned by China's Wingtech Technology since 2018-2019. The company is Dutch-based and Chinese-owned, a distinction worth holding onto because coverage of the 2025-26 dispute has repeatedly conflated the two.
On 30 September 2025 the Dutch Minister of Economic Affairs invoked the Goods Availability Act, a 1952 law never previously used, freezing changes to Nexperia's assets, intellectual property, business activities and personnel for up to a year. Ownership stayed with Wingtech throughout; the Act froze the company's operations rather than transferring or nationalising it. China's Ministry of Commerce responded by barring Nexperia's Dongguan site, roughly 70% of its total end-product capacity, from exporting certain finished components without licence, a block lifted on 9 November 2025 but rejected by Wingtech as insufficient. Wingtech sued Nexperia in a Chinese court on 22 May 2026 for around €1 billion over the Dutch intervention .
Nexperia previously owned the UK's Newport Wafer Fab but was ordered to divest 86% of it under a Final Order issued 16 November 2022; Vishay Intertechnology completed its acquisition of the Newport site in March 2024, so Nexperia has held no stake in that plant for over two years.